Oncology Institute, Inc. (TOI) CMO sells 23,452 shares after option exercises
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Oncology Institute, Inc. Chief Medical Officer Yale Podnos reported an option exercise-and-sale sequence on July 14, 2026. He exercised stock options for a total of 23,452 common shares at strike prices of $2.00 and $1.87, then sold all corresponding shares in open-market trades at prices of $6.35 and $6.429. The transactions were executed under a pre-arranged Rule 10(b) 5-1 trading plan. Following these trades, he directly holds 259,527 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 23,452 shares ($150,340)
Net Sell
6 txns
Insider
Podnos Yale
Role
Chief Medical Officer
Sold
23,452 shs ($150K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 17,974 | $1.87 | $34K |
| Exercise | Stock Option (Right to Buy) | 5,478 | $2.00 | $11K |
| Exercise | Common Stock | 17,974 | $1.87 | $34K |
| Sale | Common Stock | 17,974 | $6.429 | $116K |
| Exercise | Common Stock | 5,478 | $2.00 | $11K |
| Sale | Common Stock | 5,478 | $6.35 | $35K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 277,501 shares (Direct)
Footnotes (1)
- The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025. The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms. The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1.
Key Figures
Shares sold: 23,452 shares
Sale prices: $6.35 and $6.429 per share
Option exercise strike prices: $2.00 and $1.87 per share
+3 more
6 metrics
Shares sold
23,452 shares
Total common shares sold in open-market transactions on July 14, 2026
Sale prices
$6.35 and $6.429 per share
Prices received for 5,478 and 17,974 common shares sold
Option exercise strike prices
$2.00 and $1.87 per share
Strike prices for options exercised into 5,478 and 17,974 common shares
Post-transaction holdings
259,527 shares
Direct common stock ownership by Yale Podnos after July 14, 2026 trades
Options exercised
23,452 shares
Total common shares underlying stock options exercised on July 14, 2026
Rule 10(b) 5-1 plan adoption date
08/26/2025
Date Yale Podnos adopted the trading plan governing the sale transactions
Key Terms
Rule 10(b) 5-1 trading plan, Stock Option (Right to Buy, derivative security, open-market sale, +1 more
5 terms
Rule 10(b) 5-1 trading plan regulatory
"The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan"
Stock Option (Right to Buy financial
"security_title": "Stock Option (Right to Buy)""
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
exercise or conversion financial
"transaction_action": "derivative exercise/conversion""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did TOI Chief Medical Officer Yale Podnos report in this Form 4?
Yale Podnos reported exercising stock options for 23,452 Oncology Institute (TOI) shares and selling the same number of shares in open-market transactions on July 14, 2026, as part of a pre-arranged trading plan.
What stock options did Yale Podnos exercise in the TOI Form 4 filing?
He exercised options covering 5,478 shares at a $2.00 strike price and 17,974 shares at a $1.87 strike price. These options were originally granted on November 17, 2022 and May 21, 2024 and vested under their original terms.